Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Common variable immune deficiency | 32 | 25 | |
Hypogammaglobulinemia | 16 | 14 | |
Chronic inflammatory demyelinating polyneuropathy | 6 | 14 | |
IgG deficiency | 5 | 2 | |
Specific antibody deficiency | 3 | 2 |
Common side effects
Side effect | Patients | Percentage |
---|---|---|
Fatigue | 5 | |
Injection site pain | 5 | |
Injection site swelling | 4 | |
Headaches | 3 | |
Abdominal pain | 2 | |
Diarrhea | 2 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 2 | |
Moderate | 13 | |
Mild | 31 | |
None | 10 |